Dermapharm Holding Se Stock Performance
| DMPHF Stock | 39.56 0.00 0.00% |
The firm shows a Beta (market volatility) of 0.0, which means not very significant fluctuations relative to the market. the returns on MARKET and Dermapharm Holding are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Dermapharm Holding SE has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable technical indicators, Dermapharm Holding is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 120.3 M | |
| Total Cashflows From Investing Activities | -129.3 M |
Dermapharm |
Dermapharm Holding Relative Risk vs. Return Landscape
If you would invest 3,956 in Dermapharm Holding SE on September 27, 2025 and sell it today you would earn a total of 0.00 from holding Dermapharm Holding SE or generate 0.0% return on investment over 90 days. Dermapharm Holding SE is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded pink sheets are less volatile than Dermapharm, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Dermapharm Holding Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Dermapharm Holding's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Dermapharm Holding SE, and traders can use it to determine the average amount a Dermapharm Holding's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| DMPHF |
Based on monthly moving average Dermapharm Holding is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Dermapharm Holding by adding Dermapharm Holding to a well-diversified portfolio.
Dermapharm Holding Fundamentals Growth
Dermapharm Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Dermapharm Holding, and Dermapharm Holding fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Dermapharm Pink Sheet performance.
| Return On Equity | 0.38 | |||
| Return On Asset | 0.12 | |||
| Profit Margin | 0.17 % | |||
| Operating Margin | 0.26 % | |||
| Current Valuation | 2.75 B | |||
| Shares Outstanding | 53.84 M | |||
| Price To Book | 4.81 X | |||
| Price To Sales | 2.24 X | |||
| Revenue | 942.91 M | |||
| EBITDA | 357.41 M | |||
| Total Debt | 565.71 M | |||
| Book Value Per Share | 9.36 X | |||
| Cash Flow From Operations | 250.37 M | |||
| Earnings Per Share | 3.51 X | |||
| Total Asset | 1.41 B | |||
About Dermapharm Holding Performance
By analyzing Dermapharm Holding's fundamental ratios, stakeholders can gain valuable insights into Dermapharm Holding's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Dermapharm Holding has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Dermapharm Holding has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Things to note about Dermapharm Holding performance evaluation
Checking the ongoing alerts about Dermapharm Holding for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Dermapharm Holding help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Dermapharm Holding generated a negative expected return over the last 90 days | |
| About 65.0% of the company shares are held by company insiders |
- Analyzing Dermapharm Holding's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Dermapharm Holding's stock is overvalued or undervalued compared to its peers.
- Examining Dermapharm Holding's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Dermapharm Holding's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Dermapharm Holding's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Dermapharm Holding's pink sheet. These opinions can provide insight into Dermapharm Holding's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Dermapharm Pink Sheet analysis
When running Dermapharm Holding's price analysis, check to measure Dermapharm Holding's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dermapharm Holding is operating at the current time. Most of Dermapharm Holding's value examination focuses on studying past and present price action to predict the probability of Dermapharm Holding's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dermapharm Holding's price. Additionally, you may evaluate how the addition of Dermapharm Holding to your portfolios can decrease your overall portfolio volatility.
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |